Gabriel Krivenko

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

Jennifer M. Logue, Elisa Zucchetti, Christina A. Bachmeier et al. · Haematologica · 2020 · 271 citations · Full text

Medicine, Hematology, Oncology +17

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

Erin Dean, Rahul Mhaskar, Hong Lü et al. · Blood Advances · 2020 · 242 citations · Full text

Medicine, Oncology, Pharmacology +17

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

Austin J. Sim, Michael D. Jain, Nicholas Figura et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 162 citations

Medicine, Hematology, Oncology +14

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel

Aasha I. Hoogland, Reena Jayani, Aaron Collier et al. · Cancer Medicine · 2021 · 35 citations · Full text

Medicine, Hematology, Oncology +11

Association of high baseline metabolic tumor volume with response following axicabtagene ciloleucel in refractory large B-cell lymphoma.

Erin Dean, Hong Lu, Aleksandr Lazaryan et al. · Journal of Clinical Oncology · 2019 · 13 citations

Medicine, Oncology, Pharmacology +17